StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) income statement

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.76+0.05 (+7.73%)

Close on Nov 18, 2026Market cap $6.93MP/E –Yield –

NEUROONE MEDICAL TECHNOLOGIES Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
55.6%
Operating margin
-83.4%
Net margin
-78.6%
Return on equity, FY2025
-91.3%

Financial strength

Current ratio
2.84
Debt to equity
–
Debt to assets
–
Cash to current liabilities
100.3%

Valuation

P/E ratio
–
Price to sales
0.73
Price to book
1.84
Dividend yield
–

See a number that looks wrong?